ArticlePediatric surgery international2026
Long-term outcomes of suprasternal aortopexy in paediatric patients with tracheomalacia.
Article in Pediatric surgery international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTracheomalacia is characterised by dynamic tracheal collapse causing airway obstruction, particularly during expiration. In severe cases, surgical intervention with aortopexy may be required. This study reports long-term outcomes following suprasternal aortopexy, exploring predictors of operative success/failure.
methodsAll patients undergoing aortopexy between February 2016 and May 2019 were included. Electronic patient records were reviewed for demographics, associated conditions, preoperative symptoms, dynamic flexible bronchoscopy findings and postoperative outcomes. Outcomes were categorised by degree of symptom improvement or resolution.
resultsTwenty-eight patients (22 male, 78%) underwent aortopexy at a median age of 8 months (range 19 days-5 years 9 months) with follow-up of 6 years 7 months (range 5 years 2 months-8 years 9 months). Patients were stratified into oesophageal atresia/tracheoesophageal fistula, prematurity, syndromic and primary tracheomalacia groups. Short-term improvement occurred in 75%, with complete resolution in 46%. At long-term review, 82% improved and 64% were symptom-free. Respiratory infection was the most common persistent symptom. Syndromic patients had the poorest outcomes and no later improvement.
conclusionsSuprasternal aortopexy is a safe and durable treatment for tracheomalacia. While most patients improve early, further improvement may occur over time. Caution is warranted when considering aortopexy in children with underlying systemic syndromes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.